Manufacturers Life Insurance Company, The Kronos Bio, Inc. Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 11, 2023	SELL	$3.35 - $5.55 $28,012 - $46,409	-8,362 Reduced 36.63%	14,467 $48,000
Q3 2022 Nov 03, 2022	BUY	$3.35 - $5.55 $48,464 - $80,291	14,467 New	14,467 $48,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $7.52 $71,226 - $171,674	-22,829 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$6.26 - $14.42 $142,909 - $329,194	22,829 New	22,829 $165,000
Q1 2022 May 20, 2022	BUY	$6.26 - $14.42 $9,953 - $22,927	1,590 Added 7.49%	22,829 $166,000
Q4 2021 Feb 16, 2022	BUY	$11.35 - $21.18 $13,245 - $24,717	1,167 Added 5.81%	21,239 $298,000
Q3 2021 Nov 12, 2021	SELL	$18.17 - $24.7 $29,253 - $39,767	-1,610 Reduced 7.43%	20,072 $421,000
Q2 2021 Aug 12, 2021	BUY	$20.08 - $29.02 $261,983 - $378,623	13,047 Added 151.09%	21,682 $519,000
Q1 2021 May 03, 2021	BUY	$27.0 - $32.48 $5,913 - $7,113	219 Added 2.6%	8,635 $253,000
Q4 2020 Feb 12, 2021	BUY	$26.68 - $38.23 $224,538 - $321,743	8,416 New	8,416 $251,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.